About: Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa. (en)
skos:prefLabel	Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa. (en)
name	Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa. (en)
title	wds:Q64716406-C6C4165E-F958-4DAF-BA2A-7B81FB96DB9E
title	A Phase 2 Study of the Safety and Efficacy of Hematide Injection for the Maintenance Treatment of Anemia in Subjects With Chronic Renal Failure Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa (en)
end time	wds:Q64716406-92CB92A3-7F35-4292-83C3-04F0731EF068
end time	2009-12-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q64716406-3A42494A-5CC3-4CE8-AED2-15B0337BE08B
instance of	clinical trial
start time	wds:Q64716406-1C17CAD2-C26D-429B-B323-D8FDD7A1BF0D
start time	2008-09-01 00:00:00Z (xsd:dateTime)
country	wds:Q64716406-8B565997-0C2B-4B2E-9C49-0E99516CE95B
country	United States of America
research intervention	wds:Q64716406-F1C0970D-B54C-4581-9240-CEA9625391A7
research intervention	darbepoetin alfa
minimum age	wds:Q64716406-9050AD5C-80EA-4683-8A88-F30F99459659
minimum age	18 (xsd:decimal)
medical condition	wds:Q64716406-535F4CB1-F3C8-40D8-B4DC-08295A1BD630
medical condition	anemia
number of participants	wds:Q64716406-5105D30C-1DCF-4128-8F4A-A8DEDED4EF96
number of participants	102 (xsd:decimal)
maximum age	wds:Q64716406-13A9248F-AD10-4617-8E1F-88632EB0D048
maximum age	90 (xsd:decimal)
study type	wds:Q64716406-5B19BAFE-6247-4157-97FD-66A98BFC5598
study type	interventional study
ClinicalTrials.gov ID	wds:Q64716406-EE8F2799-E7E3-460E-A2F9-8F43DAF382A0
ClinicalTrials.gov ID	NCT00752609
clinical trial phase	wds:Q64716406-35BA9DBE-346B-44F1-ABCD-85CEC26E1EEF
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64716406

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software